Clinical Trial Update: VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the VAM regimen in secondary acute myeloid leukemia, AML with extramedullary involvement, and myeloid sarcoma; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with Extramedullary Involvement
• Myeloid Sarcoma

Drugs mentioned

• VAM

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Myeloid Leukemia, Myeloid Sarcoma | Phase 2 | Status: RECRUITING